- About COS
- COS Membership
- Clinical Practice
- Canadian Journal
- Vision Health
Physicians are invited to contribute case reports to the Canadian Ocular Adverse Drug Reactions Registry, a national registry managed by The Canadian Ophthalmological Society (COS) for collecting and recording proven or suspected ocular and systemic adverse reactions to ophthalmic medications.
The registry is sponsored jointly by COS and the Product-Related Disease Division of Health Canada’s Health Protection Branch.
Adverse drug reaction case reports should include the following details:
Possible associations will be monitored and suggestions will be made for further study. Submit an Adverse Drug Reaction Report
Dr. Paul Rafuse
COS Board Liaison, Pharmacology Affairs
Canadian Ophthalmological Society
610-1525 Carling Avenue
Ottawa, ON K1Z 8R9
Reporting adverse events is a vital part of post-marketing surveillance of any new medication in determining its safety and efficacy.
Ophthalmologists have a duty of care to report suspected reactions to new medications as a critical means for information to be accurately collected and used in the interest of the vision health of all Canadians.